BladderDx – Rapid and non-invasive test for the early diagnosis of bladder cancer under Measure 4.1. Intelligent Development Operational Program 2014-2020, co-financed by the European Regional Development Fund; IV: Increasing the scientific and research potential; Action 4.1: Research and development work; Sub-measure 4.1.2: Regional scientific and research agendas.
Aim of the project: to improve the diagnosis of bladder neoplasms by introducing a non-invasive and specific test. The project aims to conduct an effective diagnostic method that monitors treatment in patients after surgery. At a later stage, a technique that allows for early cancer detection. The principle of the test operations will be detecting proteasome markers in urine which may be the result of a bladder tumor.
The total value of the project: PLN 9 913 300,00
Co-financing value: PLN 8 578 335,00
Project implementation period: 1.07.2019 – 30.06.2022
The Consortium: Institute of Biotechnology and Molecular Medicine